SCHEMBL4015453

SCHEMBL4015453

Cc1cc(Nc2nc(O[C@@H](C)c3ncc(F)cn3)ncc2C)n[nH]1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 17/20 0.81
JAK3 P52333 13/20 0.81
NTRK1 P04629 4/20 0.53
AURKB Q96GD4 3/20 0.53
AURKA O14965 3/20 0.53
PLK4 O00444 1/20 0.53
STK10 O94804 1/20 0.53
PAK4 O96013 1/20 0.53
RET P07949 1/20 0.53
FGFR1 P11362 1/20 0.53
FER P16591 1/20 0.53
CSNK2A2 P19784 1/20 0.53
JAK1 P23458 1/20 0.53
TYK2 P29597 1/20 0.53
FLT3 P36888 1/20 0.53
STAT3 P40763 1/20 0.53
STAT5A P42229 1/20 0.53
CDK3 Q00526 1/20 0.53
PTK2 Q05397 1/20 0.53
TNK2 Q07912 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4015443 1.00 JAK2 (0.81) JAK2JAK3NTRK1AURKBAURKA
SCHEMBL4006062 0.89 JAK2 (1.00) JAK2JAK3NTRK1AURKBAURKA
SCHEMBL4006048 0.89 JAK2 (1.00) JAK2JAK3NTRK1AURKBAURKA
SCHEMBL4001797 0.86 JAK2 (0.62) JAK2JAK3NTRK1AURKBRET
SCHEMBL4001803 0.86 JAK2 (0.62) JAK2JAK3NTRK1AURKBRET
SCHEMBL218888 0.79 JAK2 (1.00) JAK2JAK3NTRK1AURKBAURKA
SCHEMBL4004655 0.78 JAK2 (0.62) JAK2JAK3NTRK1AURKBRET
SCHEMBL4004658 0.78 JAK2 (0.62) JAK2JAK3NTRK1AURKBRET
SCHEMBL4007169 0.76 JAK2 (0.77) JAK2JAK3NTRK1AURKBAURKA
SCHEMBL4007173 0.76 JAK2 (0.77) JAK2JAK3NTRK1AURKBAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009007753-A2 4- (3-AMINOPYRAZOLE) -PYRIMIDINE DERIVATIVEE AND THEIR USE AS TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2009-01-15 WO disclosed